CD EGFR/ALK/ROS1 Mutations Detection Kit

Product Description

NCCN Clinical Practice Guideline for non-small cell lung cancer (NSCLC) clearly indicates that all patients with NSCLC should conduct EGFR and ALK testing before treatment with tyrosine kinase inhibitors (TKIs). If the mutations detection are negative or unknown, then ROS1 testing will be considered.
CD EGFR/ALK/ROS1 Mutations Detection Kit is specially designed to detect 18 EGFR mutations (exons 18-21), 5 ALK Gene Fusions and 9 ROS1 Gene Fusions, based on RT-PCR and ARMS-PCR technology. This Kit is a one-step real-time PCR test, combined reverse transcription and PCR amplification with novel, specific primers and fluorescent probes. The kit contains all required primers, enzymes and buffers for RNA gene fusion and DNA gene mutation detection. This Kit is optimized to deliver high sensitivity and selectivity results.
All Kit components are subjected to stringent quality control ensuring the consistency and reproducibility of PCR amplification.